Emil D. Kakkis
President & CEO at Ultragenyx Pharmaceutical. Based in Novato, California.
- Rank
- 1715th of 14,452
- Companies held
- 1
- Largest holding
- RARE, 100.0% of total
- Latest SEC filing
- Apr 16, 2026
What the $83.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical RARE Common Stock | Through Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 | 2,158,985 | $17.22 | $37.2M | 44.5% | Form 4, Mar 1, 2026 |
| Ultragenyx Pharmaceutical RARE Common Stock | Through Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200909 | 1,758,985 | $17.22 | $30.3M | 36.2% | Form 4, Apr 16, 2026 |
| Ultragenyx Pharmaceutical RARE Common Stock | Directly | 735,739 | $17.22 | $12.7M | 15.2% | Form 4, Apr 16, 2026 |
| Ultragenyx Pharmaceutical RARE Common Stock | Through GRAT | 200,000 | $17.22 | $3.4M | 4.1% | Form 4, Apr 16, 2026 |
Share counts are the amounts Emil D. Kakkis reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1712 | Kenneth S. Wilson Chief Executive Officer, Jabil. St. Petersburg, FL | $83.7M |
| 1713 | Michael J Dominguez 10% owner, DoubleVerify Holdings. Providence, RI | $83.7M |
| 1714 | Mark P. Stevenson Retiring Executive VP & COO, Thermo Fisher Scientific. Davidson, NC | $83.6M |
| 1715 | Emil D. Kakkis President & CEO, Ultragenyx Pharmaceutical. Novato, CA | $83.6M |
| 1716 | Alma Gregory Sorensen Chief Strategy Officer, RadNet. Los Angeles, CA | $83.5M |
| 1717 | Warren Gouk Chief Administrative Officer, LifeStance Health Group. Scottsdale, AZ | $83.5M |
| 1718 | Jacqueline F. Parker 10% owner, Covenant Logistics Group. Chattanooga, TN | $83.5M |
Other Ultragenyx Pharmaceutical insiders
All RARE insiders- Mardi Dier$1.1MCFO & Executive Vice President. #12612 overall
- Camille L. Bedrosian$805KEVP and Chief Medical Officer. #9589 overall
Questions
How much stock does Emil D. Kakkis own?
Emil D. Kakkis holds $83,580,869 in listed stock based on SEC filings and current prices, mostly Ultragenyx Pharmaceutical (RARE). That ranks 1715th on the Stock Rich List.
Is this Emil D. Kakkis's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Emil D. Kakkis last buy or sell stock?
The most recent open-market trade on file is a sale of 54,404 RARE shares on Mar 2, 2026 at $22.80.